首页> 外文期刊>BioProcess International >'Biopharma' As a Maturing Industry: Raw Material Selection As a Means of Process Optimization
【24h】

'Biopharma' As a Maturing Industry: Raw Material Selection As a Means of Process Optimization

机译:“Biopharma”作为成熟的行业:原料选择作为过程优化的手段

获取原文
获取原文并翻译 | 示例
           

摘要

Roquette is a family-owned French company with more than 20 manufacturing facilities and a presence in more than 100 countries. For small-molecule pharmaceuticals, it offers a broad range of excipients; for large molecules, it offers ingredients bothfor cell culture and protein stabilization. The company has more than 300 people in its R&D workforce who focus on understanding the science behind their materials. Achenbach's goal was to initiate a conversation between raw material suppliers and biopharmaceutical manufacturers and to build an understanding of the effect of raw materials on bioprocessing.
机译:Roquette是一家家庭拥有的法国公司,拥有20多家制造设施和100多个国家的展望。 对于小分子药物,它提供了广泛的赋形剂; 对于大分子,它提供了细胞培养和蛋白质稳定性的成分。 公司拥有超过300人的研发员工,专注于理解其材料背后的科学。 Achenbach的目标是在原材料供应商和生物制药制造商之间发起对话,并建立理解原材料对生物处理的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号